Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD: results from COSYCONET
MRproANP and COPAVP are prognostic markers for mortality in chronic obstructive pulmonary disease (COPD). Furthermore, these biomarkers predict mortality due to cardiovascular diseases, which are important prognostically determining comorbidities in patients with COPD. However, less is known about t...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
24 January 2024
|
| In: |
Respiratory research
Year: 2024, Volume: 25, Issue: 1, Pages: 1-9 |
| ISSN: | 1465-993X |
| DOI: | 10.1186/s12931-024-02690-9 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12931-024-02690-9 Verlag, kostenfrei, Volltext: https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-024-02690-9 |
| Author Notes: | S. Fähndrich, C. Herr, S. Teuteberg, P. Alter, S. Söhler, D. Soriano, J. Classen, J. Adams, V. Weinhold, H. Watz, B. Waschki, T. Zeller, M. Eichenlaub, F.C. Trudzinski, J.D. Michels, A. Omlor, F. Seiler, I. Moneke, F. Biertz, D. Stolz, T. Welte, H.U. Kauczor, K. Kahnert, R.A. Jörres, C.F. Vogelmeier, R. Bals, Stefan Andreas, Peter Alter, Robert Bals, the German COSYCONET Cohort |
| Summary: | MRproANP and COPAVP are prognostic markers for mortality in chronic obstructive pulmonary disease (COPD). Furthermore, these biomarkers predict mortality due to cardiovascular diseases, which are important prognostically determining comorbidities in patients with COPD. However, less is known about these biomarkers in recently diagnosed mild to moderate COPD. Therefore, we analyzed these biomarkers as potential predictors of mortality in recently diagnosed mild to moderate COPD. |
|---|---|
| Item Description: | Gesehen am 29.01.2025 |
| Physical Description: | Online Resource |
| ISSN: | 1465-993X |
| DOI: | 10.1186/s12931-024-02690-9 |